Vitamin K2 cream shows promise for youthful skin in small trial

NCT ID NCT07403942

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a face-and-neck cream containing Vitamin K2 to see if it improves skin hydration, elasticity, and wrinkles. Thirty-six women aged 35 to 60 applied the cream to one side of their face and a placebo to the other side twice daily for 8 weeks. Researchers measured skin changes using special devices and imaging to compare the two sides.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Vitamin K2 (BioYoung™ MK-7) in a topical cream
What this could lead to
If it works, this could point toward a simple cosmetic cream that improves skin firmness and reduces wrinkles without invasive procedures.
What could go wrong
This is a small, early-stage cosmetic trial with only 36 participants, so results may not apply to everyone. The improvements are likely modest and temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Dec 2024

Finished

May 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Is a Chinese female aged between 35 and 60 years (inclusive). * Presents with facial skin concerns including dryness, dullness, and laxity. * Has crow's feet (outer canthus wrinkles) with a visual assessment grade of 2 to 4 (on a 0-6 scale). * Self-reports concerns about neck wrinkles. * Is in good general health at the time of screening. * Is willing and able to provide written informed consent. * Is willing and able to comply with all study procedures and product usage requirements for the duration of the study. Exclusion Criteria: * Is planning pregnancy, is pregnant, lactating, or within 6 months postpartum. * Has a history of severe systemic diseases, immunodeficiency, or autoimmune diseases. * Has a history of allergic diseases or has experienced cosmetic allergies within the past 1-2 years. * Has had dermatological diseases on the test areas (face and neck) or is undergoing related medical treatment within the past 3 months. * Has an active cold, influenza, or other acute illness at the study start that may affect participation. * Is currently participating, or has participated within the past month, in another clinical study involving the test areas. * Is deemed unsuitable for participation by a dermatologist's assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin aging of face and neck are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Sino-German Union Cosmetic Institute Co., Ltd.

    Beijing, 100123, China